This grant supports short-term exploratory clinical trials to improve prevention, diagnosis, or treatment of arthritis, musculoskeletal, or skin diseases through early-stage research.
This grant supports investigator-initiated clinical trials in arthritis, musculoskeletal, or skin diseases, funding both trial preparation and implementation for studies ready to begin.
NIH's R21 grant supports early-stage, high-risk clinical trial research with potential for breakthroughs in biomedical, behavioral, or clinical fields.
NIAMS offers eligible career development award recipients up to $50,000 per year for two years for small research projects supporting a transition to independence; clinical trials are excluded.
Supports investigator-initiated clinical trials for neurological disorders, from early exploratory studies to Phase 3 confirmatory and comparative effectiveness trials.
NIH plans a milestone-driven award supporting planning and early to definitive clinical trials across biomedical and other interventions for up to 7 years; applications are not yet being accepted.